相关实验视频
Updated: Feb 11, 2026

11:45
Quantifying Agonist Activity at G Protein-coupled Receptors
Published on: December 26, 2011
19.8K
喘中的GLP-1受体激动剂:向代谢-炎症十字路口
Helen O'Brien1,2, Alessandro N Franciosi1,2, Marcus W Butler1,2
1Department of Respiratory Medicine, St. Vincent's University Hospital, Dublin.
Current opinion in pulmonary medicine
|February 10, 2026
概括
类似葡萄糖类-1受体激动剂在喘管理方面表现有前途,特别是在肥胖或糖尿病患者中. 需要进一步的研究,以了解它们的机制和在喘治疗中的最佳使用.
科学领域:
- 代谢医学是一种代谢医学.
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 肥胖会加剧喘,导致疾病控制不良,治疗反应减少.
- 减肥和代谢调节显示出改善喘结果的潜力.
- 新出现的证据表明,胰岛素耐药性和喘控制之间存在联系,无论体重如何.
研究的目的:
- 审查葡萄糖类-1受体激动剂 (GLP-1RAs) 在喘管理中的新兴作用.
- 探索GLP-1RAs作为控制不下的喘的附加疗法的潜力,特别是在患有并发性肥胖或糖尿病的患者中.
- 为了突出代谢和炎症途径在喘治疗中的交叉点.
主要方法:
- 审查最近的翻译,机理学和观察研究.
- 对研究喘中的GLP-1RAs的元分析的分析.
- 评估目前对喘中的GLP-1RA机制的理解.
主要成果:
- GLP-1RAs在改善肥胖和非肥胖个体的喘护理方面显示出积极的信号.
- 通过GLP-1RAs调节胰岛素抵抗可能会改善喘控制,无论体重减轻如何.
- GLP-1RAs代表了一种新的治疗方法,用于控制不良的喘的炎症和代谢联系.
结论:
- GLP-1RAs因其在治疗肥胖和/或糖尿病喘患者的潜力而得到认可.
- 在这些患者群体中GLP-1RA作用的精确机制需要进一步阐明.
- 随机对照试验对于确定GLP-1RAs的益处,危害和最佳整合到喘治疗指南中至关重要.
相关概念视频
Glucagon-like Receptor Agonists
1.0K
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.0K
Drug-Receptor Interaction: Agonist
4.1K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.1K
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
1.0K
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
1.0K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
523
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
523
Asthma-I: Introduction
3.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
What is Metabolism?
132.2K
Overview
132.2K

